Preconception cannabis use: an important but overlooked public health issue

Loading...
Thumbnail Image
Authors
Skelton, Kara R.
Young-Wolff, Kelly C.
Issue Date
2022-09-23
Type
Article
Language
en_US
Keywords
Clinicians , Marijuana , Pregnancy , Prenatal , Women
Research Projects
Organizational Units
Journal Issue
Alternative Title
Abstract
Cannabis is the most commonly used federally illicit drug among pregnant women in the United States, and the prevalence and frequency of prenatal cannabis use are increasing. The preconception period – typically thought of as the 3-12 months immediately preceding pregnancy – is a distinct and critical period for women’s health that has often been overlooked when examining prenatal cannabis use. Given that substance use behaviors typically develop before pregnancy, and risk factors associated with prenatal cannabis use are often present prior to conception, preventive approaches to addressing prenatal cannabis use would benefit from focusing on women who use cannabis prior to pregnancy. In order to ensure preconception cannabis use is brought to the forefront of cannabis prevention efforts, we recommend additional research, patient education, and clinician training focused on preconception cannabis use.
Description
Citation
Skelton, K. R., & Young-Wolff, K. C. (2022). Preconception cannabis use: An important but overlooked public health issue. Women's health (London, England), 18, 17455057221124071. https://doi.org/10.1177/17455057221124071
Publisher
Women's Health (London, England)
Journal
Volume
Issue
PubMed ID
DOI
ISSN
EISSN